BioCardia Statistics Share Statistics BioCardia has 5.5M
shares outstanding. The number of shares has increased by 47.86%
in one year.
Shares Outstanding 5.5M Shares Change (YoY) 47.86% Shares Change (QoQ) 10.64% Owned by Institutions (%) 0.04% Shares Floating 3.85M Failed to Deliver (FTD) Shares 50 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 191.11K, so 3.46% of the outstanding
shares have been sold short.
Short Interest 191.11K Short % of Shares Out 3.46% Short % of Float 3.85% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.75 and the forward
PE ratio is -1.78.
BioCardia's PEG ratio is
0.01.
PE Ratio -0.75 Forward PE -1.78 PS Ratio 103.14 Forward PS 189.3 PB Ratio 7.15 P/FCF Ratio -0.74 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for BioCardia.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.13,
with a Debt / Equity ratio of 1.14.
Current Ratio 1.13 Quick Ratio 1.13 Debt / Equity 1.14 Debt / EBITDA -0.12 Debt / FCF -0.12 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $3.41K Profits Per Employee $-467.41K Employee Count 17 Asset Turnover 0.02 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -32.02% in the
last 52 weeks. The beta is 0.81, so BioCardia's
price volatility has been higher than the market average.
Beta 0.81 52-Week Price Change -32.02% 50-Day Moving Average 2.17 200-Day Moving Average 2.28 Relative Strength Index (RSI) 34.29 Average Volume (20 Days) 304,841
Income Statement In the last 12 months, BioCardia had revenue of 58K
and earned -7.95M
in profits. Earnings per share was -2.9.
Revenue 58K Gross Profit -4.33M Operating Income -8M Net Income -7.95M EBITDA -7.93M EBIT -8M Earnings Per Share (EPS) -2.9
Full Income Statement Balance Sheet The company has 2.37M in cash and 951K in
debt, giving a net cash position of 1.42M.
Cash & Cash Equivalents 2.37M Total Debt 951K Net Cash 1.42M Retained Earnings -160.12M Total Assets 2.17M Working Capital -2.06M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.03M
and capital expenditures -6K, giving a free cash flow of -8.03M.
Operating Cash Flow -8.03M Capital Expenditures -6K Free Cash Flow -8.03M FCF Per Share -2.93
Full Cash Flow Statement Margins Gross margin is -7463.79%, with operating and profit margins of -13794.83% and -13700%.
Gross Margin -7463.79% Operating Margin -13794.83% Pretax Margin -13700% Profit Margin -13700% EBITDA Margin -13679.31% EBIT Margin -13794.83% FCF Margin -13848.28%
Dividends & Yields BCDA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for BCDA is $25,
which is 1353.5% higher than the current price. The consensus rating is "Buy".
Price Target $25 Price Target Difference 1353.5% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 30, 2024. It was a
backward
split with a ratio of 1:15.
Last Split Date May 30, 2024 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -113.53 Piotroski F-Score 3
